Page last updated: 2024-11-07

prednisolone acetate and Dermatomyositis

prednisolone acetate has been researched along with Dermatomyositis in 1 studies

prednisolone acetate: RN given refers to cpd with locant for acetate group in position 21 & (11 beta)-isomer

Dermatomyositis: A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korda, J1
Genti, G1
Káli, G1
Bálint, G1
Bátory, G1

Other Studies

1 other study available for prednisolone acetate and Dermatomyositis

ArticleYear
Successful treatment of respiratory failure associated with dermatomyositis.
    The Journal of rheumatology, 1987, Volume: 14, Issue:5

    Topics: Combined Modality Therapy; Dermatomyositis; Dexamethasone; Erythritol; Female; Humans; Intermittent

1987